![Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen](https://cdnintech.com/media/chapter/46036/1512345123/media/fig1.png)
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer](https://jkms.org/ArticleImage/0063JKMS/jkms-20-624-g002-l.jpg)
Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/Articles/821986/fonc-12-821986-HTML/image_m/fonc-12-821986-g001.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4997-y/MediaObjects/12885_2018_4997_Fig1_HTML.png)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
![SSAT - Chimeric Antibodies to CEA Improve Detection of Human Colon Cancer in Orthotopic Mouse Models SSAT - Chimeric Antibodies to CEA Improve Detection of Human Colon Cancer in Orthotopic Mouse Models](http://meetings.ssat.com/abstracts/2013/images/598_A.jpg)
SSAT - Chimeric Antibodies to CEA Improve Detection of Human Colon Cancer in Orthotopic Mouse Models
![PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/425728fadcea61776ea78a6e3ecbd2698e2a1f5d/4-Table3-1.png)
PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar
![T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis: Molecular Therapy T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis: Molecular Therapy](https://www.cell.com/cms/attachment/2083044272/2073047531/gr1.jpg)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis: Molecular Therapy
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/821986/821986_Thumb_400.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1de34a583d91d78e75729266b6207a43f586e45f/2-Table1-1.png)
Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar
![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)